Le Lézard
Classified in: Health
Subject: SVY

Parkinson's Disease- Epidemiology Forecast to 2025


NEW YORK, Nov. 17, 2017 /PRNewswire/ -- DelveInsight's "Parkinson's Disease -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Parkinson's Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).

Read the full report: https://www.reportlinker.com/p05189559

It includes 10 years epidemiology historical and forecasted data of Insulin Resistance. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Insulin Resistance. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits
? The Report includes the prevalent population and how will it change over the next eight years.
? Coverage of key Parkinson's Disease sub-populations and its prevalent or incident cases
? Prevalent or incident cases segmented by age and sex.
? The key differences in epidemiology patterns across the seven market segments.

Reasons to buy
? Developing business strategies by understanding the trends shaping and driving the global Parkinson's Disease market.
? Identifying prevalent patient populations as well as risk factors in the global Parkinson's Disease market will help to improve product design, pricing, and launch plans.
? Organize sales and marketing efforts by identifying the best opportunities for Parkinson's Disease therapeutics in each of the markets covered.

Read the full report: https://www.reportlinker.com/p05189559

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 14:05
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....

at 14:00
People USA, funded by and in partnership with the New York State Office of Mental Health (OMH), is set to open 20 new scattered site housing units that will support individuals re-entering the community from New...

at 13:45
Harbor Point at Centerville, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the third straight year. In U.S. News & World Report's third annual...

at 13:45
Crescent Point at Niantic, a Benchmark assisted living and Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Connecticut and the entire U.S. for the third straight year. In U.S. News & World...

at 13:22
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...



News published on and distributed by: